Telling axons where to go - and grow
In a recent study, Dr. Ingolf Bach and colleagues from the University of Massachusetts Medical School, Worcester and the University of Hamburg (Germany) describe a novel role for the ubiquitin/proteosome protein degradation pathway in the regulation of local actin dynamics in neurons. The authors are able to show that the ubiquitin ligase Rnf6 polyubiquitinates the kinase LIMK1, targeting...
Newly identified protein complex sheds light on axon growth mechanism
New research sheds light on the molecular mechanisms underlying
axon growth and synapse formation in the nematode worm C.elegans. In a study published today in the open access journal Journal of Biology, researchers have characterised a new protein, UNC-69, required for proper locomotion . They show that UNC-69 interacts with UNC-76 in a protein complex likely to be involved in the trafficking of...
Taxonomy
= law) may refer to either a hierarchical classification of things, or the principles underlying the classification. Almost anything, animate objects, inanimate objects, place...
Axon
or soma.
Axons are in effect the primary transmission lines of the <a href="/
?q=/
...
Treatment with Copaxone Plus Minocycline Showed Substantial
Reduction of Disease Activity in Patients with Active
Relapsing-Remitting Multiple Sclerosis
KANSAS CITY, Mo.--(BUSINESS WIRE)--May 4, 2007 - New data from arandomized, double-blind study showed that a combination ofCOP
AXONE(R) (glatiramer acetate injection) along with the oralantibiotic minocycline reduced T1 Gadolinium (Gd)-enhancing lesionsof the brain by 63 percent (p=0.08) in patients with activerelapsing-remitting multiple sclerosis (RRMS), as measured bymagnetic resonance im...
Treatment with Copaxone Plus Minocycline Showed Substantial
Reduction of Disease Activity in Patients with Active
Relapsing-Remitting Multiple Sclerosis
Treatment with Cop
axone Plus Minocycline Showed SubstantialReduction of Disease Activity in Patients with ActiveRelapsing-Remitting Multiple Sclerosis Combination Treatment With Antibiotic Further Reduced BrainLesions and Was Well Tolerated KANSAS CITY, Mo, May 4, 2007 - New data from a randomized,double-blind study showed that a combination of Cop
axone(glatiramer acetate in...
Copaxone Treatment over Two Years after Short Term Induction with
Mitoxantrone Provided Sustained Benefits to Active
Relapsing-Remitting Multiple Sclerosis Patients
KANSAS CITY, Mo.--(BUSINESS WIRE)--May 4, 2007 - New data havedemonstrated that relapsing-remitting multiple sclerosis (RRMS)patients treated with COP
AXONE(R) (glatiramer acetate injection)following brief immunosuppression with mitoxantrone experienced a90 percent reduction in magnetic resonance imaging (MRI)-monitoreddisease activity compared to their baseline. These benefits wereachieved...
Data on Higher Dose of Copaxone and Data Showing Copaxone is Most
Cost Effective
Data Published in Neurology Showed That Higher Dose of Cop
axoneIncreased Efficacy in Relapsing-remitting Multiple Sclerosis(RRMS) Doubled Dose of COP
AXONE Maintained Proven Safety Profile andFurther Reduced Relapses and Lesions JERUSALEM, Israel, April 17, 2007 – A 9-month, randomized,double-blind, parallel-group Phase II study of 90 patientscomparing a...
Data Published in Neurology Showed That Higher Dose of Copaxone
Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS)
JERUSALEM--(BUSINESS WIRE)--Apr 17, 2007 - A 9-month, randomized,double-blind, parallel-group Phase II study of 90 patientscomparing a 40 mg dose of COP
AXONE(R) given daily to the currentlyapproved COP
AXONE(R) 20 mg dose showed a 38 percent greaterreduction in inflammatory disease activity as measured by magneticresonance images (MRI) of the brain. In addition, patients takingCOP
AXONE(R) 40...
More>>